Breaking News Instant updates and real-time market news.

MYL

Mylan

$31.36

-0.31 (-0.98%)

06:32
11/06/18
11/06
06:32
11/06/18
06:32

Mylan Q3 better than feared, recent selloff overdone, says JPMorgan

JPMorgan analyst Chris Schott views Mylan's Q3 results as "better than feared" and a "step in the right direction." While the company's North American business remains under pressure, year-over-year erosion for the business improved from Q2, overall gross margins showed solid year-over-year improvement and Mylan maintained its annual guidance, Schott tells investors in a post-earnings research note. The analyst views the recent weakness in the shares as overdone and keeps an Overweight rating on the name with a $45 price target. Looking beyond near-term challenges, Mylan is one of the better-positioned players in the space with a number of longer-term growth drivers in place, including biosimilars and the pending generic Advair approval, says Schott.

  • 13

    Nov

MYL Mylan
$31.36

-0.31 (-0.98%)

10/09/18
10/09/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Exelon (EXC) downgraded to Neutral from Overweight at JPMorgan and to Neutral from Buy at Citi. 2. CommScope (COMM) downgraded to Neutral from Buy at Goldman Sachs with analyst Mark Delaney saying he views the company's fundamental environment as "mixed" and views the stock's valuation as fair at current levels. 3. Mylan (MYL) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst David Risinger saying recent generics trends leave him seeing downside risk to consensus forecasts and Mylan's 2018 guidance. 4. Blackbaud (BLKB) downgraded to Market Perform from Outperform at Raymond James and JMP Securities as well as to Hold from Buy at Benchmark. 5. Kroger (KR) downgraded to Sell from Hold at Deutsche Bank while Smart & Final Stores (SFS) was downgraded to Hold from Buy. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/12/18
WELS
10/12/18
NO CHANGE
WELS
Market Perform
Merck returning Lantus biosimilar rights negative for Mylan, says Wells Fargo
Wells Fargo analyst David Maris sees a negative read-through for Mylan regarding yesterday's news of Merck Sharp & Dohme Research returning the rights to biosimilar Lantus to Samsung Bioepis. While some view this as a positive, as there will likely be one fewer competitor in the market if Mylan-Biocon make it to the U.S. market, that is a "simplistic and optimistic" take, Maris tells investors in a research note. The more important factor to consider is the "why" Merck dropped out, rather than the number of competitors, the analyst writes. He believes Merck returned the rights to Samsung Bioepis due to the deteriorating pricing environment and pricing outlook for insulin and Lantus biosimilars. Lilly's and Sanofi's manufacturing capacity, along with aggressive discounting, has created a "severe pricing environment," Maris contends. He believes that if Samsung Bioepis and Merck can't make the economics work, than one should be skeptical of Mylan and Biocon having substantial success. Maris has a Market Perform rating on Mylan shares.
10/18/18
WELS
10/18/18
NO CHANGE
WELS
Sandoz results 'potential warning signal' for generics, says Wells Fargo
Wells Fargo analyst David Maris views this morning's results from Novartis' (NVS) generic unit Sandoz as "another negative datapoint" for generic stocks, notably Teva (TEVA), Mylan (MYL) and Amneal Pharmaceuticals (AMNX). Novartis reported Sandoz net sales of $2.4B, down 4% on constant currency, and noted that sales were pressured by 8% pricing erosion in the quarter, Maris tells investors in a research note. Novartis also highlighted that U.S sales for Sandoz declined 17% due to "industry wide pricing pressure," Maris points out. The analyst views the quarter as a "potential warning signal" for the Q3 earnings season for companies with large U.S. commodity generic exposure. He maintains his caution on "generic industry margin risks."
11/01/18
WELS
11/01/18
NO CHANGE
WELS
Market Perform
Fear of missing out helping to push Teva, Mylan higher, says Wells Fargo
Wells Fargo analyst David Maris believes Teva (TEVA) shares are bouncing back to fair value from recent declines after the company reported Q3 earnings that beat his above consensus estimate and hosted a "surprisingly bullish" quarterly call. He also sees a spillover effect occurring with Mylan (MYL) as the generic sector's advance reinforces buyers' belief that the stocks are undervalued and investors' "fear of missing out" drives increased interest. While Maris acknowledges Ajovy, Austedo, cost cuts and tax management are doing well, he believes much of Teva's business continues to show significant challenges and keeps a Market Perform rating on the shares.

TODAY'S FREE FLY STORIES

FB

Facebook

$141.20

-3.75 (-2.59%)

13:20
11/12/18
11/12
13:20
11/12/18
13:20
Hot Stocks
Facebook experiencing service issues »

Visiting Facebook.com…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

F

Ford

$9.53

0.15 (1.60%)

13:20
11/12/18
11/12
13:20
11/12/18
13:20
Options
Ford calls active as shares advance »

Ford calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 13

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
11/12/18
11/12
13:17
11/12/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$38.13

-0.21 (-0.55%)

13:16
11/12/18
11/12
13:16
11/12/18
13:16
Hot Stocks
Trump quotes FBN's Gasparino on cable association's 'big problems' with Comcast »

President Donald Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
11/12/18
11/12
13:16
11/12/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEP

PepsiCo

$117.77

0.25 (0.21%)

13:15
11/12/18
11/12
13:15
11/12/18
13:15
Options
PepsiCo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 15

    Feb

DISCA

Discovery

$32.83

-0.15 (-0.45%)

13:08
11/12/18
11/12
13:08
11/12/18
13:08
Recommendations
Discovery analyst commentary  »

Discovery acquisition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XBI

SPDR S&P BIOTECH

$77.95

-2.82 (-3.49%)

13:00
11/12/18
11/12
13:00
11/12/18
13:00
Options
Put spreads in SPDR S&P Biotech Fund as bearish positions are adjusted »

Put spreads in SPDR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$6.68

-0.12 (-1.76%)

12:59
11/12/18
11/12
12:59
11/12/18
12:59
Periodicals
Snap's VP of Content, Nick Bell, leaving today, Cheddar reports »

Snap's Vice…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 28

    Nov

LITE

Lumentum

$39.50

-16.45 (-29.40%)

, AAPL

Apple

$195.96

-8.35 (-4.09%)

12:57
11/12/18
11/12
12:57
11/12/18
12:57
Recommendations
Lumentum, Apple analyst commentary  »

Craig-Hallum cuts…

LITE

Lumentum

$39.50

-16.45 (-29.40%)

AAPL

Apple

$195.96

-8.35 (-4.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

HD

Home Depot

$183.19

-2.85 (-1.53%)

, TSN

Tyson Foods

$61.79

-0.3 (-0.48%)

12:52
11/12/18
11/12
12:52
11/12/18
12:52
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

HD

Home Depot

$183.19

-2.85 (-1.53%)

TSN

Tyson Foods

$61.79

-0.3 (-0.48%)

AAP

Advance Auto Parts

$168.30

-2.88 (-1.68%)

ARMK

Aramark

$35.10

-0.49 (-1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 03

    Mar

DF

Dean Foods

$6.10

0.12 (2.01%)

12:50
11/12/18
11/12
12:50
11/12/18
12:50
Options
Dean Foods draws call buying after volatility in shares last week »

Dean Foods draws call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

AGR

Avangrid

$49.35

0.43 (0.88%)

, UNH

UnitedHealth

$273.75

-2.93 (-1.06%)

12:45
11/12/18
11/12
12:45
11/12/18
12:45
Hot Stocks
Avangrid names Peter Church chief HR officer »

Avangrid (AGR) announced…

AGR

Avangrid

$49.35

0.43 (0.88%)

UNH

UnitedHealth

$273.75

-2.93 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

RIG

Transocean

$10.17

-0.36 (-3.42%)

12:40
11/12/18
11/12
12:40
11/12/18
12:40
Options
Transocean puts active as shares slip »

Transocean puts active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$33.40

-0.59 (-1.74%)

12:35
11/12/18
11/12
12:35
11/12/18
12:35
Options
Blackstone put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATHN

Athenahealth

$132.00

11.63 (9.66%)

12:26
11/12/18
11/12
12:26
11/12/18
12:26
Downgrade
Athenahealth rating change  »

Athenahealth downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$12.90

0.205 (1.61%)

12:20
11/12/18
11/12
12:20
11/12/18
12:20
Options
Vote of confidence in US Oil Fund as shares tick higher »

Vote of confidence in US…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/12/18
11/12
12:17
11/12/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/12/18
11/12
12:16
11/12/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$9.80

-0.315 (-3.11%)

12:15
11/12/18
11/12
12:15
11/12/18
12:15
Options
Deutsche Bank put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$64.55

-1.18 (-1.80%)

12:13
11/12/18
11/12
12:13
11/12/18
12:13
Periodicals
Citi seeks bigger Paris office ahead of Brexit, FT reports »

Citigroup is eyeing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

CSLT

Castlight Health

$2.68

-0.01 (-0.37%)

12:11
11/12/18
11/12
12:11
11/12/18
12:11
Conference/Events
Castlight Health management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 27

    Nov

AAPL

Apple

$195.42

-8.89 (-4.35%)

, LITE

Lumentum

$38.36

-17.59 (-31.44%)

12:09
11/12/18
11/12
12:09
11/12/18
12:09
OnTheFly
Fly Intel: Wall Street's top stories at midday »

Stocks opened in negative…

AAPL

Apple

$195.42

-8.89 (-4.35%)

LITE

Lumentum

$38.36

-17.59 (-31.44%)

BABA

Alibaba

$142.11

-2.75 (-1.90%)

PCG

PG&E

$33.72

-6.17 (-15.47%)

EIX

Edison International

$55.03

-5.96 (-9.77%)

SAP

SAP

$101.49

-6.84 (-6.31%)

ATHN

Athenahealth

$132.04

11.67 (9.70%)

APTI

Apptio

$37.60

12.76 (51.37%)

OPK

Opko Health

$3.70

0.595 (19.16%)

BTI

British American Tobacco

$38.56

-3.18 (-7.62%)

GNC

GNC Holdings

$3.36

-0.87 (-20.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 26

    Nov

PHG

Philips

$37.67

-0.58 (-1.52%)

12:04
11/12/18
11/12
12:04
11/12/18
12:04
Hot Stocks
Philips announces first U.S. patient enrolled in ILLUMENATE BTK IDE study »

Royal Philips announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

MSI

Motorola Solutions

$127.46

-2.24 (-1.73%)

, MSFT

Microsoft

$106.99

-2.55 (-2.33%)

12:02
11/12/18
11/12
12:02
11/12/18
12:02
Hot Stocks
Motorola Solutions selects Microsoft Azure Government cloud for Command »

Motorola Solutions (MSI)…

MSI

Motorola Solutions

$127.46

-2.24 (-1.73%)

MSFT

Microsoft

$106.99

-2.55 (-2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 13

    Nov

  • 26

    Nov

  • 28

    Nov

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.